Reference | Country | Sample | Gene | Mutation | Gain/loss of function | Method | Main Findings |
---|---|---|---|---|---|---|---|
Damaj et al. [10] | Canada | 16 individuals with ASD-like behavioral deficits | CACNA1A | (1)deletion (2) point mutation | loss-of-function | whole genome sequencing | Results from sequencing revealed one CACNA1A gene deletion as well as two deleterious CACNA1A point mutations including one known stop-gain and one new frameshift variant and a new splice-site variant, which pointed to an association between CACNA1A variants and ASD symptoms. |
Pinggera et al .[33] | Austria | tsA-201 cells | CACNA1D | de novo variant | gain-of-function | whole-cell patch-clamp | The study identified two de novo mutation, p.A749G and p.G407R, in ASD subjects, both demonstrated a pronounced gain-of-function. |
Splawski et al .[43] | USA | 461ASD 480controls | CACNA1H | rare missense variant | lose of function | (1) Genotypic Analyses (2) DNA Sequence Analyses | The study identified missense mutations in CACNA1H in 6 of 461 individuals with ASD. |
Splawski et al .[42] | USA | 13 TS 13 controls | CACNA1C | de novo missense variant | gain-of-function | (1) Genotypic Analyses (2) DNA Sequencing | The result showed that the CACNA1C gain-of-function mutation causes the diverse physiological and developmental defects in TS. |
Li et al .[23] | China | 553 trios | CACNA1A | SNPs | (1) SNP selection (2) SNP genotyping | The study identified association of rs7249246 and rs12609735 with ASD. | |
Strom et al .[45] | USA | 284 trios | CACNA1G | SNPs | (1) SNP selection (2) SNP genotyping | Markers within an interval containing the gene, CACNA1G, were found to be associated with ASD at a locally significant level. | |
Smith et al .[41] | USA | (1)69 ASD (2)35 parents (3)89 CEU HapMap controls | CACNA2D4 | CNVs | Microarray analyses | The study identified a rare homozygous deletion in a male proband that removed one copy of the CACNA2D4 calcium channel genes(12p13.33) | |
Pinggera et al .[34] | Germany | (1)1ASD (2)tsA-201 cells | CACNA1D | de novo missense variant | gain-of-function | (1) DNA Sequencing (2)whole-cell patch-clamp | The study identified a de novo missense mutation in CACNA1D (V401L) in a patient with ASD. |
Breitenkamp et al .[5] | Germany | (1)155 ASD (2)259 controls | CACNB2 | rare missense variant | gain-of-function | (1) Genotypic Analyses (2) DNA Sequencing | The study identified three missense mutations in CACNB2 gene in ASD subjects that result in a decelerated inactivation of the Cav1.2 subunit |
Li et al .[23] | China | 553 trios | CACNA1C | SNPs | (1) SNP selection (2) SNP genotyping | The result found a nominal significant association between two SNPs (rs1006737 and rs4765905) in CACNA1C and ASD. | |
Lu et al .[25] | USA | 2781 trios | (1)CACNA1C (2)CACNA1G (3)CACNA1I | SNPs | (1) SNP selection (2) SNP genotyping | Four SNPs in three CCGs were associated with ASD. One, rs10848653, is located in CACNA1C.Two others, rs198538 and rs198545, located in CACN1G, and a fourth, rs5750860, located in CACNA1I. | |
Iossifov et al .[21] | USA | 343 families with ASD | CACNA2D3 | de novo variant | DNA Sequencing | The result identified a variation in CACNA2D3 that disrupted a splice junction associated with ASD (A/G). | |
Wang et al .[47] | USA | (1)780 families with ASD (2)1204 affected subjects (3)6491 control subjects | CACNA1C | SNPs | genome-wide SNP genotyping | The result found an relationship between SNPs in CACNA1C and ASD | |
Cross-Disorder Group [9] | USA | (1)33,332ASD (2)27,888 controls | (1)CACNA1C (2)CACNB2 | SNPs | genome-wide SNP genotyping | The result showed that SNPs within CACNA1C and CACNB2 were associated with ASD. | |
Hemara-Wahanui et al .[18] | New Zealand | 27 families with ASD | CACNA1F | nucleotide substitution | gain-of-function | (1) DNA Sequencing (2) Functional Analyses | The molecular genetic analyses revealed an I745T CACNA1F allele in a New Zealand family, some male probands also affected with ASD. |
Myers et al .[27] | USA | (1)142 ASD (2)143 SCZ (3) 240controls | CACNA1F | rare missense variant | DNA Sequencing | The study found a rare causal CACNA1F variants associated with ASD. | |
Palmieri et al .[32] | USA | (1)6ASD (2)6controls | Ca2+ concentration | Fluorimetric measure of Ca2+ | The study found a significantly higher level of Ca2+ in ASD patients as compared to healthy controls. | ||
Schmunk et al .[39] | USA | skin fibroblast cultures | IP3-mediated Ca 2+ release | High-throughput Ca2+ imaging | The study found a significantly reduction in IP3-mediated Ca2+ release from the ER. | ||
Wen et al .[48] | USA | ASD genes | (1) Gene set enrichment analysis (2)Pathway-pathway interactions | The results showed that the process “calcium-PRC (protein kinase C)-Ras-Raf-MAPK/ERK” was a major contributor to ASD pathophysiology. | |||
Skafidas et al .[40] | Australia | (1) Index sample:2609 ASD (2) Vlidation sample:737 ASD | CACNA1A | SNPs | Gene set enrichment analysis | The result showed that SNPs in CACNA1A to be among the top 15 SNPs contributing to the ASD diagnosis | |
Schmunk et al .[38] | USA | skin fibroblast cultures | IP3-mediated Ca 2+ release | High-throughput Ca2+ imaging | The study found a significantly depressed IP3-mediated Ca2+ signals in ASD. | ||
O'Roak et al .[31] | USA | 209 trios | (1)CACNA1D (2)CACNA1E | CNVs | Exome read-depth CNV analysis | The result showed that rare de novo alleles of CACNA1D and CACNA1E contributed to the genetic etiology of ASD. | |
De Rubeis et al .[11] | USA | (1) 3871 ASD (2)9937 controls | (1)CACNA2D3 (2) CACNA1D | de novo variant | loss of function | Exome sequencing | The result identified two de novo CACNA2D3 loss of function mutations in ASD cases and none in controls. |
Girirajan et al .[17] | USA | (1) 2588 ASD (2) 580 controls | CACNA2D3 | CNVs | Microarray analyses | The study reported an enrichment of CACNA2D3 deletion in ASD subjects compared to controls | |
Jiang et al. [22] | USA | 32 families with ASD | CACNA1C | rare missense variant | Whole-genome sequencin | It found a rare missense mutation in CACNA1C (R1522Q) in a proband with ASD and an unaffected sibling. | |
Yuen et al. [51] | Canada | 85 quartet families (parents and two ASD-affected siblings) | CACNB2 | rare missense variant | Whole-genome sequencing | It found a CACNB2 (V2D) mutation in two affected siblings. | |
Yatsenko et al .[50] | USA | 20 ASD | CACNA1B | duplication | (1) whole genome sequencing (2) custom 9q34 microarray | The study found a duplication of the chromosomal region 9q43.3, comprising the gene CACNA1B, in 12 out of 20 patients. | |
Prasad et al .[36] | USA | (1)696 unrelated ASD (2)1000 controls | CACNA2D4 | CNVs | CGH microarray | The study identified multiple novel CNVs in ASD subjects, including the loss of CACNA2D4. |